ELIZABETH KIDDER: Open Payments
NPI 1407276587 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 47 payments from 22 companies in 2025. Trend: 2023 $1,032 · 2024 $1,222 · 2025 $935
Food & beverage: $885Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $134 |
| Gilead Sciences, Inc. | 5 | $99 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Neurocrine BioSciences, Inc. | 4 | $80 |
| Abbott Laboratories | 2 | $73 |
| ABBVIE INC. | 3 | $63 |
| Braeburn Inc. | 3 | $54 |
| Alkermes, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
Products named: INGREZZA, BRIXADI, FREESTYLE INSULINX, TRELEGY ELLIPTA, Wegovy, ARISTADA, SHINGRIX, SPRAVATO.
Industry payments across NY — which companies pay providers there.
